Shopping Cart
Remove All
Your shopping cart is currently empty
Synonyms:
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $330 | - | In Stock | |
| 5 mg | $856 | - | In Stock | |
| 10 mg | $1,370 | - | In Stock |
| Description | Baminercept (BG 9924) is a lymphotoxin-β receptor-immunoglobulin fusion protein that blocks the lymphotoxin-α/LIGHT axis. Baminercept selectively binds to the ligand of the lymphotoxin-β receptor (LTβR), thereby blocking LTβR signaling and influencing the migration of immune cells. Baminercept also increases the number of lymphocytes in the blood and reduces plasma CXCL13 levels. Baminercept is being studied for the treatment of primary Sjögren’s syndrome (SS) and rheumatoid arthritis (RA). |
| In vivo | Baminercept (100 mg/kg) induces maternal liver toxicity in some pregnant rats, but does not have this effect in macaques or non-pregnant rats.[1] |
| Reactivity | Human |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Formulation | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| Endotoxin | <0.9 EU/mg |
| Conjucates | Unconjugated |
| Target | LTβ |
| Molecular Weight | 46.88 kDa |
| Cas No. | 909110-25-4 |
| Storage | Store at low temperature -20°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.